Figure 4.
![Graph of forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), and DLCO (percentage) in relation to immunosuppressive therapy (prednisone and ibrutinib [mg]) and HCT-OP relapse for case 3.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/144/10/10.1182_blood.2023023249/2/blood_bld-2023-023249-c-gr4.jpeg?Expires=1761139424&Signature=Q5tQT0h~urNDXERraIqFkis-zMqRiJBKdv3MKW~MGx8Ws2Yni2LAW4PZSnOJ-J~~s~iaKqqU7~0QImMiPXEp~QpLLv-T-RJiU0B6zcIASqur1CHrRUjzZSv0LQD~wl3mDzjqIee1zAcPzH1qGhMS~DPkx2rkvNoRFVCHfEJTCCLNS9aV5wiI~zGthMcq6KWYt2XSCLXVSYCxEUu9r~VEQMzmeKKBpBVrq-FnhtStP7uaGQZbjHT5-laIdx18rsfkfFmpvlI6EStgzHDy1nvW5ZLph09pWuRHOpFd1y6PZf3zmF3uBPiZnmy3dKKE3JcSN3kVXuhvVFcQYCO7rcWbvA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Graph of forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), and DLCO (percentage) in relation to immunosuppressive therapy (prednisone and ibrutinib [mg]) and HCT-OP relapse for case 3.
Graph of forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), and DLCO (percentage) in relation to immunosuppressive therapy (prednisone and ibrutinib [mg]) and HCT-OP relapse for case 3.
